MiR-16 repressed CRC cell growth by decreasing Survivin (BIRC5) expression through a direct targeting of BIRC5, and p53 negatively modulated BCL-2 by controlling miR-1915 [65,66]. This evidence concerns the gene BIRC5 and colorectal carcinoma.